Skip to main content
Top
Published in: European Journal of Nutrition 4/2017

01-06-2017 | Original Contribution

Trans-fatty acid levels in erythrocytes in Europe

Authors: Clemens von Schacky, Adrian Passow, Rosemarie Kiefl

Published in: European Journal of Nutrition | Issue 4/2017

Login to get access

Abstract

Purpose

High, but not low levels of trans-fatty acids (TFA) in erythrocytes are associated with increased mortality. Current erythrocyte TFA levels in Europe are not known.

Methods

TFA levels in samples submitted by physicians for erythrocyte omega-3 fatty acid analyses are reported, as analysed with a method (HS-Omega-3 Index®) previously used in pertinent prospective epidemiologic studies. From Germany, 6754 samples were included from 2008 through 2015, and 496 samples from 10 other European countries.

Results

In Germany, mean levels of C16:1n-7t, a marker for dairy and meat intake, decreased, as did mean levels of industrially produced (IP)-TFA, as did the percentage of individuals with IP-TFA > 1.04 %. Mean levels of IP-TFA in Austria and Switzerland were low before and after measures were taken to reduce them. Average levels of C16:1n-7t were low, and at levels associated with increased risk of death in previous studies. A limitation of our study is that samples were not obtained in a specific or representative manner.

Conclusions

Levels of IP-TFA appear to be decreasing, as are those of ruminant-derived C16:1n-7t, a marker for dairy and meat intake. Few individuals had high levels of IP-TFA above a safe range, while many had low levels of C16:1n-7t. Our data argue against further action against TFA in the countries studied. More systematic biomarker-based studies are needed.
Literature
1.
go back to reference Ganguly R, Pierce GN (2015) The toxicity of dietary trans fats. Food Chem Toxicol 78:170–176CrossRef Ganguly R, Pierce GN (2015) The toxicity of dietary trans fats. Food Chem Toxicol 78:170–176CrossRef
2.
go back to reference Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L et al (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 160:398–406CrossRef Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L et al (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 160:398–406CrossRef
3.
go back to reference de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T et al (2015) Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. Br Med J 351:h3978CrossRef de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T et al (2015) Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. Br Med J 351:h3978CrossRef
4.
go back to reference Brownell KD, Pomeranz JL (2014) The trans-fat ban—food regulation and long-term health. N Engl J Med 370:1773–1775CrossRef Brownell KD, Pomeranz JL (2014) The trans-fat ban—food regulation and long-term health. N Engl J Med 370:1773–1775CrossRef
5.
go back to reference Stender S, Astrup A, Dyerberg J (2012) A trans European Union difference in the decline in trans fatty acids in popular foods: a market basket investigation. BMJ Open. doi:10.1136/bmjopen-2012-000859 Stender S, Astrup A, Dyerberg J (2012) A trans European Union difference in the decline in trans fatty acids in popular foods: a market basket investigation. BMJ Open. doi:10.​1136/​bmjopen-2012-000859
6.
go back to reference Kleber M, Delgado GE, Lorkowski S, März W, von Schacky C (2015) Trans fatty acids and mortality in patients referred for coronary angiography—The Ludwigshafen Risk and Cardiovascular Health Study. Eur Heart J. doi:10.1093/eurheartj/ehv446 Kleber M, Delgado GE, Lorkowski S, März W, von Schacky C (2015) Trans fatty acids and mortality in patients referred for coronary angiography—The Ludwigshafen Risk and Cardiovascular Health Study. Eur Heart J. doi:10.​1093/​eurheartj/​ehv446
7.
go back to reference de Oliveira Otto MC, Nettleton JA, Lemaitre RN, Steffen LM, Kromhout D, Rich SS et al (2013) Biomarkers of dairy fatty acids and risk of cardiovascular disease in the Multi-ethnic Study of Atherosclerosis. J Am Heart Assoc 2(4):e000092CrossRef de Oliveira Otto MC, Nettleton JA, Lemaitre RN, Steffen LM, Kromhout D, Rich SS et al (2013) Biomarkers of dairy fatty acids and risk of cardiovascular disease in the Multi-ethnic Study of Atherosclerosis. J Am Heart Assoc 2(4):e000092CrossRef
8.
go back to reference Yakoob MY, Shi P, Hu FB, Campos H, Rexrode KM, Orav EJ, Willett WC, Mozaffarian D (2014) Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohorts. Am J Clin Nutr 100:1437–1447CrossRef Yakoob MY, Shi P, Hu FB, Campos H, Rexrode KM, Orav EJ, Willett WC, Mozaffarian D (2014) Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohorts. Am J Clin Nutr 100:1437–1447CrossRef
9.
go back to reference Sun Q, Ma J, Campos H, Hu FB (2007) Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. Am J Clin Nutr 86:929–937 Sun Q, Ma J, Campos H, Hu FB (2007) Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. Am J Clin Nutr 86:929–937
10.
go back to reference Bendsen NT, Christensen R, Bartels EM, Astrup A (2011) Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr 65:773–783CrossRef Bendsen NT, Christensen R, Bartels EM, Astrup A (2011) Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr 65:773–783CrossRef
11.
go back to reference Sun Q, Ma J, Campos H, Hankinson SE, Manson JE, Stampfer MJ, Rexrode KM et al (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115:1858–1865CrossRef Sun Q, Ma J, Campos H, Hankinson SE, Manson JE, Stampfer MJ, Rexrode KM et al (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115:1858–1865CrossRef
12.
go back to reference Liu XR, Deng ZY, Hu JN, Fan YW, Liu R, Li J et al (2013) Erythrocyte membrane trans-fatty acid index is positively associated with a 10-year CHD risk probability. Br J Nutr 109:1695–1703CrossRef Liu XR, Deng ZY, Hu JN, Fan YW, Liu R, Li J et al (2013) Erythrocyte membrane trans-fatty acid index is positively associated with a 10-year CHD risk probability. Br J Nutr 109:1695–1703CrossRef
13.
go back to reference Block RC, Harris WS, Reid KJ, Spertus JA (2008) Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J 156:1117–1123CrossRef Block RC, Harris WS, Reid KJ, Spertus JA (2008) Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J 156:1117–1123CrossRef
14.
go back to reference Wang Q, Imamura F, Lemaitre RN, Rimm EB, Wang M, King IB et al (2014) Plasma phospholipid trans-fatty acids levels, cardiovascular diseases, and total mortality: the cardiovascular health study. J Am Heart Assoc 3(4):000914 Wang Q, Imamura F, Lemaitre RN, Rimm EB, Wang M, King IB et al (2014) Plasma phospholipid trans-fatty acids levels, cardiovascular diseases, and total mortality: the cardiovascular health study. J Am Heart Assoc 3(4):000914
15.
go back to reference Jacobs S, Schiller K, Jansen E, Fritsche A, Weikert C, di Giuseppe R et al (2014) Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study. Eur J Clin Nutr 68:517–525CrossRef Jacobs S, Schiller K, Jansen E, Fritsche A, Weikert C, di Giuseppe R et al (2014) Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study. Eur J Clin Nutr 68:517–525CrossRef
16.
go back to reference Decsi T, Campoy C, Demmelmair H, Szabó E, Marosvölgyi T, Escolano M et al (2011) Inverse association between trans isomeric and long-chain polyunsaturated fatty acids in pregnant women and their newborns: data from three European countries. Ann Nutr Metab 59:107–116CrossRef Decsi T, Campoy C, Demmelmair H, Szabó E, Marosvölgyi T, Escolano M et al (2011) Inverse association between trans isomeric and long-chain polyunsaturated fatty acids in pregnant women and their newborns: data from three European countries. Ann Nutr Metab 59:107–116CrossRef
17.
go back to reference Harris WS, Pottala JV, Vasan RS, Larson MG, Robins SJ (2012) Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans. J Nutr 142:1297–1303CrossRef Harris WS, Pottala JV, Vasan RS, Larson MG, Robins SJ (2012) Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans. J Nutr 142:1297–1303CrossRef
18.
go back to reference Harris WS, Pottala JV, Varvel SA, Borowski JJ, Ward JN, McConnell JP (2013) Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients. Prostaglandins Leukot Essent Fatty Acids 88:257–263CrossRef Harris WS, Pottala JV, Varvel SA, Borowski JJ, Ward JN, McConnell JP (2013) Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients. Prostaglandins Leukot Essent Fatty Acids 88:257–263CrossRef
19.
go back to reference Harris WS, Reid KJ, Sands SA, Spertus JA (2007) Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 99:154–158CrossRef Harris WS, Reid KJ, Sands SA, Spertus JA (2007) Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 99:154–158CrossRef
20.
go back to reference von Schacky C (2015) Omega-3 fatty acids in cardiovascular disease—an uphill battle. Prostaglandins Leukotr Ess Fatty Acids 92:41–47CrossRef von Schacky C (2015) Omega-3 fatty acids in cardiovascular disease—an uphill battle. Prostaglandins Leukotr Ess Fatty Acids 92:41–47CrossRef
21.
go back to reference Harris WS, Thomas RM (2010) Biological variability of blood omega-3 biomarkers. Clin Biochem 43:338–340CrossRef Harris WS, Thomas RM (2010) Biological variability of blood omega-3 biomarkers. Clin Biochem 43:338–340CrossRef
22.
go back to reference Jaudszus A, Kramer R, Pfeuffer M, Roth A, Jahreis G, Kuhnt K (2014) trans Palmitoleic acid arises endogenously from dietary vaccenic acid. Am J Clin Nutr 99:431–435CrossRef Jaudszus A, Kramer R, Pfeuffer M, Roth A, Jahreis G, Kuhnt K (2014) trans Palmitoleic acid arises endogenously from dietary vaccenic acid. Am J Clin Nutr 99:431–435CrossRef
23.
go back to reference Stergiadis S, Bieber A, Franceschin E, Isensee A, Eyre MD, Maurer V et al (2015) Impact of US Brown Swiss genetics on milk quality from low-input herds in Switzerland: interactions with grazing intake and pasture type. Food Chem 175:609–618CrossRef Stergiadis S, Bieber A, Franceschin E, Isensee A, Eyre MD, Maurer V et al (2015) Impact of US Brown Swiss genetics on milk quality from low-input herds in Switzerland: interactions with grazing intake and pasture type. Food Chem 175:609–618CrossRef
24.
go back to reference Kusche D, Kuhnt K, Ruebesam K, Rohrer C, Nierop AF, Jahreis G, Baars T (2015) Fatty acid profiles and antioxidants of organic and conventional milk from low- and high-input systems during outdoor period. J Sci Food Agric 95:529–539CrossRef Kusche D, Kuhnt K, Ruebesam K, Rohrer C, Nierop AF, Jahreis G, Baars T (2015) Fatty acid profiles and antioxidants of organic and conventional milk from low- and high-input systems during outdoor period. J Sci Food Agric 95:529–539CrossRef
25.
go back to reference Mozaffarian D, Ludwig DS (2015) The 2015 US dietary guidelines: lifting the ban on total dietary fat. J Am Med Assoc 313:2421–2422CrossRef Mozaffarian D, Ludwig DS (2015) The 2015 US dietary guidelines: lifting the ban on total dietary fat. J Am Med Assoc 313:2421–2422CrossRef
26.
go back to reference Hulshof KF, van Erp-Baart MA, Anttolainen M, Becker W, Church SM, Couet C et al (1999) Intake of fatty acids in western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur J Clin Nutr 53:143–157CrossRef Hulshof KF, van Erp-Baart MA, Anttolainen M, Becker W, Church SM, Couet C et al (1999) Intake of fatty acids in western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur J Clin Nutr 53:143–157CrossRef
27.
go back to reference Wolin E, White J, Pottala JV, Sasinowski M, Dall T, Dayspring TD et al (2015) Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population. J Clin Lipidol. doi:10.1016/j.jacl.2015.07.014 Wolin E, White J, Pottala JV, Sasinowski M, Dall T, Dayspring TD et al (2015) Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population. J Clin Lipidol. doi:10.​1016/​j.​jacl.​2015.​07.​014
28.
go back to reference Archer E, Hand GA, Blair SN (2013) Validity of U.S. nutritional surveillance: National Health and Nutrition Examination Survey caloric energy intake data, 1971–2010. PLoS One 8:e76632CrossRef Archer E, Hand GA, Blair SN (2013) Validity of U.S. nutritional surveillance: National Health and Nutrition Examination Survey caloric energy intake data, 1971–2010. PLoS One 8:e76632CrossRef
29.
go back to reference Schuchardt JP, Hahn A (2013) Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 89:1–8CrossRef Schuchardt JP, Hahn A (2013) Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 89:1–8CrossRef
Metadata
Title
Trans-fatty acid levels in erythrocytes in Europe
Authors
Clemens von Schacky
Adrian Passow
Rosemarie Kiefl
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 4/2017
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-016-1218-9

Other articles of this Issue 4/2017

European Journal of Nutrition 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.